A phase I/II trial of SBI1997 patients with hepatocellular carcinoma

Trial Profile

A phase I/II trial of SBI1997 patients with hepatocellular carcinoma

Planning
Phase of Trial: Phase I/II

Latest Information Update: 29 Dec 2015

At a glance

  • Drugs SBI 1997 (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms AUDIT
  • Most Recent Events

    • 29 Dec 2015 New trial record
    • 18 Dec 2015 Saronic Biotechnology has filed an IND with the FDA, and this trial is expected to begin in Q1-Q2 2016, according to a Saronic Biotechnology media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top